TFF Pharmaceuticals: R&D facility in Texas
Thin-film freezing specialist TFF Pharmaceuticals has announced plans to expand its manufacturing capacity with a new R&D facility in Austin, Texas. The 3,500-square-foot facility adds a dedicated lab for downstream processing of products created with the company’s thin-film-freezing technology.
John Koleng, vice president of product development and manufacturing, said, “The Austin facility will enable us to increase testing capacity so that we can run a larger number of feasibility studies, including a focus on biologics where demand has continued to grow. Additionally, as many of our partnered programs move to clinical evaluation, the ability to scale-up manufacturing in parallel becomes mission critical. We expect the new Austin facility will allow us to meet the current growing demand for thin-fim freezing-based products.”